Gavin MacBeath is Chief Executive Officer and Director of TScan Therapeutics, Inc. (TCRX). The company reported total compensation of $2,801,450 for fiscal year 2025.
| Salary | $665,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $1,982,800 |
| Non-equity incentive plan | $139,650 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,000 |
| Total | $2,801,450 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure TScan Therapeutics, Inc. filed April 17, 2026, accession 0001193125-26-160304.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Gavin MacBeath this page | Chief Executive Officer and Director | $2,801,450 |
| Chrystal Louis | Chief Medical Officer | $1,609,600 |
| Jason Amello | Chief Financial Officer and Treasurer | $1,275,995 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full TScan Therapeutics, Inc. compensation brief.
Gavin MacBeath's compensation sits inside TScan Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.